Search
Immutep Ltd
IMMPAdd to Watchlist
0.376USD
+0.002+0.59%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
54.93MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
2
analysts
Buy
Current Rating
9.723
Target Price
+2525.83%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Immutep Ltd
IMMP
2
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Immutep Ltd's price target?
Analysts forecast that Immutep Ltd's price target is USD 8.26, with the highest forecast at USD 12.00 and the lowest forecast at USD 4.53.
What is the analyst rating for Immutep Ltd?
Based on the ratings of Immutep Ltd's stock from 2 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
